Specificity determinants of CYP1B1 estradiol hydroxylation

Molecular Pharmacology

Volumn 84, Issue 3, 2013, Pages 451-458

  Nishida, Clinton R ^a   Everett, Steven ^b   De Montellano, Paul R Ortiz ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cyterix Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOCHROME P450 1B1; ESTRADIOL; LEUCINE;

ARTICLE; CARCINOGENICITY; DOG; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; HAPLORHINI; HUMAN; HYDROXYLATION; MOLECULAR DOCKING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEQUENCE ANALYSIS;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; DOGS; ESTRADIOL; HUMANS; HYDROXYLATION; MACACA MULATTA; MICE; MOLECULAR DOCKING SIMULATION; MUTAGENESIS, SITE-DIRECTED; NADPH-FERRIHEMOPROTEIN REDUCTASE; RATS; SPECIES SPECIFICITY;

EID: 84883163985     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.087700     Document Type: Article

References (32)

1. Badawi AF, Cavalieri EL, and Rogan EG (2001) Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism 50: 1001-1003.
2. Buters JTM, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, and Gonzalez FJ (1999) Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96: 1977-1982.
3. Choudhary D, Jansson I, and Schenkman JB (2009) CYP1B1, a developmental gene with a potential role in glaucoma therapy. Xenobiotica 39: 606-615.
4. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, and Schenkman JB (2004) Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 32: 840-847.
5. De Vivo I, Hankinson SE, Li L, Colditz GA, and Hunter DJ (2002) Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 11: 489-492.
6. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, and Sutter TR (1996) 17 b-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93: 9776-9781.
7. Itoh T, Takemura H, Shimoi K, and Yamamoto K (2010) A 3D model of CYP1B1 explains the dominant 4-hydroxylation of estradiol. J ChemInfModel 50: 1173-1178.
8. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, and Lopez R et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
9. Lee AJ, Cai MX, Thomas PE, Conney AH, and Zhu BT (2003) Characterization of the oxidative metabolites of 17b-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 144: 3382-3398.
10. Lewis DFV, Gillam EMJ, Everett SA, and Shimada T (2003) Molecular modelling of human CYP1B1 substrate interactions and investigation of allelic variant effects on metabolism. Chem Biol Interact 145: 281-295.
11. Ma X, Idle JR, Krausz KW, and Gonzalez FJ (2005) Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos 33: 489-494.
12. Murray GI, Taylor MC, McFadyen MCE, McKay JA, Greenlee WF, Burke MD, and Melvin WT (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57: 3026-3031.
13. Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, and Johnson EF (2007) Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem 282: 14348-14355.
14. Savas U, Bhattacharyya KK, Christou M, Alexander DL, and Jefcoate CR (1994) Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression. J Biol Chem 269: 14905-14911.
15. Savas U, Carstens CP, and Jefcoate CR (1997) Biological oxidations and P450 reactions. Recombinant mouse CYP1B1 expressed in Escherichia coli exhibits selective binding by polycyclic hydrocarbons and metabolism which parallels C3H10T1/2 cell microsomes, but differs from human recombinant CYP1B1. Arch Biochem Biophys 347: 181-192.
16. Scornaienchi ML, Thornton C, Willett KL, and Wilson JY (2010) Cytochrome P450- mediated 17b-estradiol metabolism in zebrafish (Danio rerio). J Endocrinol 206: 317-325.
17. Shimada T, El-Bayoumy K, Upadhyaya P, Sutter TR, Guengerich FP, and Yamazaki H (1997) Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Cancer Res 57: 4757-4764.
18. Shimada T, Murayama N, Tanaka K, Takenaka S, Guengerich FP, Yamazaki H, and Komori M (2011) Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds. Chem Res Toxicol 24: 1327-1337.
19. Shimada T, Oda Y, Gillam EMJ, Guengerich FP, and Inoue K (2001a) Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab Dispos 29: 1176-1182.
20. Shimada T, Watanabe J, Inoue K, Guengerich FP, and Gillam EMJ (2001b) Specificity of 17b-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432. Xenobiotica 31: 163-176.
21. Shimada T, Wunsch RM, Hanna IH, Sutter TR, Guengerich FP, and Gillam EMJ (1998a) Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Arch Biochem Biophys 357: 111-120.
22. Shimada T, Yamazaki H, Foroozesh M, Hopkins NE, Alworth WL, and Guengerich FP (1998b) Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Chem Res Toxicol 11: 1048-1056.
23. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, and Söding J et al. (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539.
24. Spink DC, Spink BC, Zhuo X, Hussain MM, Gierthy JF, and Ding X (2000) NADPHand hydroperoxide-supported 17b-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1. J Steroid Biochem Mol Biol 74: 11-18.
25. Sutter TR, Tang YM, Hayes CL, Wo YY, Jabs EW, Li X, Yin H, Cody CW, and Greenlee WF (1994) Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269: 13092-13099.
26. Trott O and Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31: 455-461.
27. Vasiliou V and Gonzalez FJ (2008) Role of CYP1B1 in glaucoma. Annu Rev Pharmacol Toxicol 48: 333-358.
28. Wang A, Savas U, Stout CD, and Johnson EF (2011) Structural characterization of the complex between a-naphthoflavone and human cytochrome P450 1B1. J Biol Chem 286: 5736-5743.
29. Watanabe J, Shimada T, Gillam EMJ, Ikuta T, Suemasu K, Higashi Y, Gotoh O, and Kawajiri K (2000) Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10: 25-33.
30. Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, and Nakajima M et al. (2002) Roles of NADPHP450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24: 329-337.
31. Yamazaki H, Shaw PM, Guengerich FP, and Shimada T (1998) Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11: 659-665.
32. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, and Gao YT (2000) Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9: 147-150.